GSX1 and astrocytoma (excluding glioblastoma): Through single-cell RNA sequencing, we identified a distinct GSX1+ tumor subpopulation specifically enriched in high-grade IDH-mutant astrocytoma (WHO grades 3–4), localized at the pseudotime trajectory terminus and associated with poor prognosis and immunosuppressive phenotype.